R
Live / Registered — Registered (as of 16 Sept 2025)
What this means for you
Registered since 16 Sept 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79396229
- Registration number
- 7943034
- Mark type
- Design + words
- Filed
- 12 Apr 2024
- Published for opposition
- 29 Jul 2025
- Registered
- 16 Sept 2025
- Attorney of record
- Cheryl L. Burbach
Goods and services
- Class 005 — Pharmaceuticals: Medical, biological, and pharmaceutical preparations for the treatment of viral infections, bacterial infections, cancer, viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; veterinary preparations for pets, cattle, livestock, for the treatment of viral infections, bacterial infections, cancer, viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medical, biological, and pharmaceutical preparations for preventing and treating viral, bacterial, and yeast infections; veterinary preparations for pets, cattle, livestock, for preventing and treating viral, bacterial, and yeast infections; medical, biological, and pharmaceutical preparations for preventing and treating cancer, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; veterinary preparations for pets, cattle, livestock for preventing and treating cancer, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines; sanitary preparations for medical purposes; dietary supplements and dietetic preparations adapted for medical purposes; dietetic foods adapted for medical use; diagnostic preparations for medical purposes; diagnostic chemical reagents for medical use; clinical medical reagents
- Class 042 — Scientific and technological services: Biological research; clinical research in the field of age-related diseases and cancer; medical research; research and development services in the field of pharmaceutical preparations; pharmaceutical products development; pharmaceutical product evaluation; research and development in the field of microorganisms and cells; research on the subject of pharmaceuticals; testing of pharmaceuticals; laboratory research services relating to pharmaceutical product development; development of gene-based medicines; drug discovery services; scientific research in the nature of conducting clinical trials for others relating to pharmaceutical products; scientific laboratory services; laboratory research services relating to pharmaceuticals; scientific risk assessment being consultation in the field of health risk assessment, namely, prediction and assessment of health risks to public and private agencies, facilities, individuals and locations following an accidental or terrorist caused release of chemical, biological, radiological or nuclear materials; consulting services in the field of pharmaceutical research; testing of pharmaceuticals being services for assessing the efficiency of pharmaceuticals; pharmaceutical toxicity testing for research purposes; pharmaceutical toxicity analysis services for scientific research purposes; computer services, namely, remote management of the information technology (IT) systems of others for the pharmaceutical and healthcare industries; conducting early evaluations in the field of new pharmaceuticals; providing information about scientific research, namely, the results of clinical trials for pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; chemical research and analysis services; medical and pharmacological research services; scientific services, namely, scientific research in the field of genetics; scientific research for medical purposes in the field of age-related diseases and cancer; medical and scientific research, namely, conducting clinical trials for others; scientific research in the field of genetics; genetic mapping for scientific purposes; DNA screening for scientific research purposes; providing scientific research information in the field of pharmaceuticals for the treatment of medical disorders; technical research in the field of pharmaceutical studies; veterinary research; design and development of computer software relating to the medical field; design and development of computer software relating to healthcare; computer programming in the medical field; scientific computer programming services; providing temporary use of non-downloadable software for capturing, storing, processing, evaluating and reproducing medical and pharmaceutical data; providing temporary use of on-line non-downloadable computer programs on data networks using artificial intelligence (AI) for use in the life sciences research field, pharmaceutical research, medical research, drug discovery and development; platform as a service (PAAS) featuring computer software platforms using artificial intelligence (AI) for use in the life sciences research field, pharmaceutical research, medical research, drug discovery and development; software as a service (SaaS) services featuring software for capturing, storing, processing, evaluating and reproducing medical and pharmaceutical data in the life sciences research field, pharmaceutical research, medical research, drug discovery and development; software as a service (SaaS) featuring software using artificial intelligence (AI) for capturing, storing, processing, evaluating and reproducing medical and pharmaceutical data in the life sciences research field, pharmaceutical research, medical research, drug discovery and development; software as a service (SaaS) featuring software using artificial intelligence (AI) for analysis of self-assessment of illnesses; software as a service (SaaS) featuring software using artificial intelligence (AI) for machine learning in the field of healthcare; software as a service (SaaS) featuring health monitoring software; software as a service (SaaS) featuring software for analyzing biological genetic data; technology consultation in the field of artificial intelligence (AI); research in the field of artificial intelligence (AI)
Owner
Prosecution history
- 28 Mar 2026 — FINAL DISPOSITION NOTICE SENT TO IB
- 27 Mar 2026 — FINAL DISPOSITION PROCESSED
- 16 Dec 2025 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 22 Nov 2025 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 14 Nov 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 22 Oct 2025 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 22 Oct 2025 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 16 Sept 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 16 Sept 2025 — REGISTERED-PRINCIPAL REGISTER
- 29 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Jul 2025 — PUBLISHED FOR OPPOSITION
- 23 Jul 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Jun 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 01 May 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 01 May 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE